Episode details

Available for over a year
The US Senate has approved spending plans to avoid a government shutdown. We get an update from the BBC's Michelle Fleury in New York. At the same time, Democratic leaders are also trying to reach an agreement over a multi-trillion dollar spending programme. The BBC's Rob Young examines the background to the current impasse. Also in the programme, at the start of the coronavirus pandemic, German company CureVac was thought by many to be one of the best prospects to develop a Covid-19 vaccine. The company's chief executive Franz Haas explains why their vaccine candidate was not as effective as had been hoped, and how the firm hopes to move forward with a second generation vaccine for the disease. (Picture: The US Capitol building. Picture credit: Getty Images.)
Programme Website